瑞普生物：公司目前已建成菌丝蛋白中试生产线

Core Insights - The company, Ruipu Biotech, announced a change in the use of part of the funds raised from a specific stock issuance, redirecting them towards the construction of a "Biomanufacturing Industrialization Project" with a total investment of 679 million yuan, of which 296 million yuan will come from the raised funds [2] Group 1 - The project aims to establish a demonstration project for the industrialization of tens of thousands of tons of microbial protein, focusing on producing mycelium protein raw materials and related products [2] - The target markets include high-growth sectors such as meat alternatives, protein beverages, protein powders, high-protein health snacks, and dairy products, highlighting the advantages of microbial protein over traditional meat proteins, including lower fishy taste, better texture, lower production costs, and higher amino acid content [2] - The company has already built a pilot production line for mycelium protein and completed the research on the production process, indicating a solid foundation for industrialization and promotion [2] Group 2 - The new production facility is currently under construction, and according to the feasibility study report, the project is expected to generate an annual revenue of 1.3 billion yuan upon full production [2] - The revenue forecast is based on the feasibility study report and may be influenced by market conditions, construction progress, capacity ramp-up, and product promotion, suggesting potential variability in actual performance [2]